Pharmaceutical Cartridges Market expected to reach US$3.265 billion by 2030

The global pharmaceutical cartridge market is expected to grow at a CAGR of 3.23% over the forecast period to reach a total market size of US$3.265 billion by 2030, increasing from US$2.785 billion in 2025.

Pharmaceutical Cartridges Market Trends & Forecast

The market is propelled by increased investment in the healthcare sector, growing adoption of self-administration devices, stringent regulatory requirements, and increasing geriatric population. The global expansion of the pharmaceutical industry, driving the demand for cartridges as a packaging solution, such as in September 2024, Stevanato Group S.p.A., Gerresheimer AG, and SCHOTT Pharma AG & Co. KGaA, announced that they have entered into a strategic industry alliance to support market adoption of Ready-to-Use (RTU) vials and cartridges. The Alliance for RTU aimed to share with pharmaceutical companies, CMOs and CDMOs technical knowledge in high-quality sterile primary packaging, specifically ready-to-fill vials and cartridges.

Additionally, adding to the production capacity, in May 2024, Stevanato Group S.p.A. announced the inauguration of its Cisterna di Latina plant. It is located just a few kilometers from the plant in Latina, the new site covers an area of 65,000 square meters and employs around 200 people. The facility started commercial production in Q4 2023 and houses advanced production lines developed by Stevanato Group for the production of EZ-fill pre-sterilized syringes. The production facility is aimed at the modern challenges of the European market, constantly growing in biopharmaceuticals, such as GLP-1s. Furthermore, the Company is planning to implement production with EZ-fill pre-sterilized cartridges between 2025 and 2026 as the site becomes fully operational. Stevanato Group is a leading provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and biotechnology industries.

Advancement in the technologies in the production technology serves as a significant factor propelling the market. In February 2024, INCOG BioPharma Services, added a high-speed OPTIMA filling line that will provide an additional 100 million units of syringe and cartridge filling capacity. INCOG secured $75 million of funding for this expansion efforts. It would complement the company’s existing filling line, bringing the company’s total filling capacity to 140 million units per year. In addition to the new filling line, INCOG recently added automated visual inspection capabilities and completed qualification of equipment to support auto-injector device assembly services.

Further, in July 2024, SCHOTT Pharma launched large format ready-to-use cartridges for on-body devices. These are used to treat cancer, metabolic disorders, cardiovascular conditions, genetic disorders, and immunological diseases, they are designed to store highly sensitive biologics. By partnering with device manufacturer Ypsomed, SCHOTT Pharma’s new RTU cartridges are compatible with the on-body device YpsoDose. The fully assembled device is the first on the market that is prefilled and pre-loaded.

SCHOTT Pharma currently has over 6,200 injectable drugs in the drug development pipeline, of which roughly 80% are biologics. These drugs typically must be stored in innovative containers to ensure drug stability. Moreover, particularly biologics with high viscosity or those that need to be injected in high volumes require unique solutions that ensure safe and reliable administration. Ypsomed and SCHOTT Pharma cooperation would provide the new ready-to-use large format cartridges.

➥ View a sample of the report or purchase the complete study at: Pharmaceutical Cartridges Market

Pharmaceutical Cartridges Market Report Highlights

• Glass is witnessing a significant growth by the non-reactive and recyclable nature. It is preferred for the sensitive biologics.
• Plastic cartridges are gaining popularity due to their lightweight, breakage resistance, and compatibility with a wide range of drugs.
• The 5ml to 10ml sized segment is growing at a robust rate due to its demand in the regular use.
• Greater than 10m are used for specialized applications, including certain biologics and drugs administered in the hospital. These are having high demand in cancer treatment, cardiovascular conditions treatment, diagnostics, genetic disorders, and immunological diseases.
• The pharmaceutical company, is significantly growing as cartridges represent a significant advancement in enhanced reliability and efficiency in pharmaceutical processes.
• Asia Pacific will be the notably growing market during the forecast period, driven by huge population, industrialization and urbanization and investment in healthcare sector in countries like China and India.

Pharmaceutical Cartridges Market Segmentation

Knowledge Sourcing Intelligence has segmented the pharmaceutical cartridges market based on material, cartridge size, end user, and region:

Pharmaceutical Cartridges Market, By Material

• Glass
• Plastic

Pharmaceutical Cartridges Market, By Cartridge Size

• Less than 3ml
• 3ml to 5ml
• 5ml to 10ml
• Greater than 10ml

Pharmaceutical Cartridges Market, By End User

• Pharmaceutical Company
• Biotech Company
• Biomedical Research Organization

Pharmaceutical Cartridges Market, By Region

• North America
  • U.S.
  • Canada
  • Mexico
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • Rest of the Middle East and Africa
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific

 

Pharmaceutical Cartridges Market Key Players

• Gerresheimer AG
• Stevanato Group
• SCHOTT AG
• West Pharmaceutical Services, Inc.
• Transcoject GmbH
• Sigma-Aldrich, Inc.
• Nipro Corporation
• Dätwyler Holding Inc.
• Shandong Province Medicinal Glass Co., Ltd.